A Computational Model of the Circulating Renin-Angiotensin System and Blood Pressure Regulation

被引:0
作者
François Guillaud
Patrick Hannaert
机构
[1] Inserm U927,
[2] CHU La Milétrie,undefined
来源
Acta Biotheoretica | 2010年 / 58卷
关键词
Renin-angiotensin system; Blood pressure; Sodium; Body fluids; Kidney; Juxtaglomerular apparatus; Models (theoretical);
D O I
暂无
中图分类号
学科分类号
摘要
The renin-angiotensin system (RAS) is critical in sodium and blood pressure (BP) regulation, and in cardiovascular-renal (CVR) diseases and therapeutics. As a contribution to SAPHIR project, we present a realistic computer model of renin production and circulating RAS, integrated into Guyton’s circulatory model (GCM). Juxtaglomerular apparatus, JGA, and Plasma modules were implemented in C ++/M2SL (Multi-formalism Multi-resolution Simulation Library) for fusion with GCM. Matlab© optimization toolboxes were used for parameter identification. In JGA, renin production and granular cells recruitment (GCR) are controlled by perfusion pressure (PP), macula densa (MD), angiotensin II (Ang II), and renal sympathetic activity (RSNA). In Plasma, renin and ACE (angiotensin-converting enzyme) activities are integrated to yield Ang I and II. Model vs. data deviation is given as normalized root mean squared error (nRMSE; n points). Identification: JGA and Plasma parameters were identified against selected experimental data. After fusion with GCM: (1) GCR parameters were identified against Laragh’s PRA-natriuresis nomogram; (2) Renin production parameters were identified against two sets of data ([renin] transients vs. ACE or renin inhibition). Finally, GCR parameters were re-identified vs. Laragh’s nomogram (nRMSE 8%, n = 9). Validation: (1) model BP, PRA and [Ang II] are within reported ranges, and respond physiologically to sodium intake; (2) short-term Ang II infusion induces reported rise in BP and PRA. The modeled circulating RAS, in interaction with an integrated CVR, exhibits a realistic response to BP control maneuvers. This construction will allow for modelling hypertensive and CVR patients, including salt-sensitivity, polymorphisms, and pharmacotherapeutics.
引用
收藏
页码:143 / 170
页数:27
相关论文
共 225 条
[1]  
Abitbol CL(2009)Nephron mass and cardiovascular and renal disease risks Semin Nephrol 29 445-454
[2]  
Ingelfinger JR(2007)Quantitative circulatory physiology: an integrative mathematical model of human physiology for medical education Adv Physiol Educ 31 202-210
[3]  
Abram SR(1978)The half-lives of angiotensin II, angiotensin II-amide, angiotensin III, Sar1-Ala8-angiotensin II and renin in the circulatory system of the rat J Physiol 278 471-490
[4]  
Hodnett BL(2007)The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition J Manag Care Pharm 13 9-20
[5]  
Summers RL(1998)Human vascular renin-angiotensin system and its functional changes in relation to different sodium intakes Hypertension 31 836-842
[6]  
Coleman TG(1991)Macula densa control of renin secretion Renal Physiol Biochem 14 164-174
[7]  
Hester RL(2007)Renin: friend or foe? Heart (British Cardiac Society) 93 1026-1033
[8]  
Al-Merani SA(2003)Better blood pressure control: how to combine drugs J Hum Hypertens 17 81-86
[9]  
Brooks DP(2009)Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement Clin Chem 55 867-877
[10]  
Chapman BJ(1971)Angiotensin II blood-levels in human hypertension Lancet 1 459-464